Name: Phase 2 PROSPECT Study Presented by Lakshmi Nayak, MD.
Uploaded: 2025-06-11T00:00:00+00:00
Description: Lakshmi Nayak, MD presented results from a phase 2 PROSPECT study focused on tirabrutinib and it's effect on patients with relapsed or refractory primary central nervous system lymphoma.

Lakshmi Nayak, MD presented results from a phase 2 PROSPECT study focused on tirabrutinib and it's effect on patients with relapsed or refractory primary central nervous system lymphoma.

Related Presenters

Lakshmi Nayak, MD

Neuro-oncology

Dr. Lakshmi Nayak serves as Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She received her medical degree at Grant Medical College ...

View full profile

Oncology

Phase 2 PROSPECT Study Presented by Lakshmi Nayak, MD.